01 2ADO-TRASTUZUMAB EMTANSINE
02 3ALTEPLASE
03 2ATEZOLIZUMAB
04 1ATEZOLIZUMAB AND HYALURONIDASE-TQJS
05 6BALOXAVIR MARBOXIL
06 2BEVACIZUMAB
07 1COBIMETINIB FUMARATE
08 1CROVALIMAB-AKKZ
09 1DORNASE ALFA
10 4EMICIZUMAB
11 5ENTRECTINIB
12 1FARICIMAB-SVOA
13 2GLOFITAMAB-GXBM
14 2INAVOLISIB
15 2MOSUNETUZUMAB-AXGB
16 1OBINUTUZUMAB
17 1OCRELIZUMAB
18 1OCRELIZUMAB AND HYALURONIDASE-OCSQ
19 4OMALIZUMAB
20 1PERTUZUMAB
21 2PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF
22 4PIRFENIDONE
23 2POLATUZUMAB VEDOTIN-PIIQ
24 3RANIBIZUMAB
25 2RISDIPLAM
26 2RITUXIMAB
27 2RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
28 1SATRALIZUMAB
29 8SOMATROPIN
30 1SOMATROPIN [rDNA origin]
31 1TENECTEPLASE
32 4TOCILIZUMAB
33 1TRASTUZUMAB
34 1TRASTUZUMAB AND HYALURONIDASE-OYSK
35 1VISMODEGIB
01 6CAPSULE;ORAL
02 1FOR SOLUTION;ORAL
03 3FOR SUSPENSION;ORAL
04 5INJECTABLE; INJECTION
05 1INJECTABLE; INTRAVITREAL
06 22INJECTABLE;INJECTION
07 1INJECTABLE;INTRAVENOUS
08 1INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
09 3INJECTABLE;SUBCUTANEOUS
10 2Injectable; Injection
11 1PELLETS;ORAL
12 2POWDER;INTRAVENOUS
13 1SOLUTION;INJECTION
14 2SOLUTION;INTRAVENOUS
15 2SOLUTION;SUBCUTANEOUS
16 3SYRINGE
17 10TABLET;ORAL
18 4VIAL
19 3VIAL; INTRAVENOUS
20 5VIAL; SINGLE-USE
01 10.75MG/ML
02 11,200MG;600MG;30,000UNITS
03 11000MG/40ML
04 4100MG
05 1100MG/10ML (10MG/ML)
06 1100MG/ML
07 1100MG/VIAL
08 1105MG/0.7ML
09 110MG/10ML(1MG/ML)
10 310MG/2ML (5MG/ML)
11 110MG/ML
12 110MG/VIAL
13 21200MG/20ML
14 2120MG/ML
15 1125MG;2000UNITS PER ML
16 11400MG and 23400UNITS/11.7ML
17 1140MG/VIAL
18 2150MG
19 1150MG/ML
20 1150MG/VIAL
21 11600MG and 26800UNITS/13.4ML
22 1160MG
23 1162MG/0.9ML
24 21MG/ML
25 12.5MG/2.5ML(1MG/ML)
26 2200MG
27 1200MG/10ML
28 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
29 220MG/2ML (10MG/ML)
30 121MG/ML
31 2267MG
32 12MG/ML
33 12MG/VIAL
34 1300MG/2ML
35 130MG/1ML
36 130MG/30ML
37 130MG/ML
38 130MG/PACKET
39 130MG/VIAL
40 1340MG/2ML(170MG/ML)
41 13MG
42 1400MG
43 1400MG/20ML
44 140MG
45 140MG/PACKET
46 140MG;1000UNITS PER ML
47 1420MG/14ML
48 1500MG/50ML (10MG/ML)
49 150MG/PACKET
50 250MG/VIAL
51 1534MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
52 15MG
53 15MG/2ML (2.5MG/ML)
54 15MG/VIAL
55 1600MG;10000UNITS
56 1600MG;600MG;20,000UNITS
57 160MG/0.4ML
58 16MG/ML
59 175MG/0.5ML
60 1801MG
61 180MG
62 180MG/4ML
63 19MG
64 1EQ 20MG BASE
65 1N/A
01 2DISCN
02 17RX
03 59Blank
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : KADCYLA
Dosage Strength : 100MG
Approval Date :
Application Number : 125427
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : KADCYLA
Dosage Strength : 160MG
Approval Date :
Application Number : 125427
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : ACTIVASE
Dosage Strength : 100MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : ACTIVASE
Dosage Strength : 50MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL
Proprietary Name : CATHFLO ACTIVASE
Dosage Strength : 2MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ
Dosage Strength : 1200MG/20ML
Approval Date :
Application Number : 761034
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ
Dosage Strength : 1200MG/20ML
Approval Date :
Application Number : 761041
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
ATEZOLIZUMAB AND HYALURONIDASE-TQJS
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ HYBREZA
Dosage Strength : 125MG;2000UNITS PER ML
Approval Date :
Application Number : 761347
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code :
Dosage Form : FOR SUSPENSION; ORAL
Proprietary Name : XOFLUZA
Dosage Strength : 2MG/ML
Approval Date : 2020-11-23
Application Number : 214410
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : FOR SUSPENSION; ORAL
Proprietary Name : XOFLUZA
Dosage Strength : 30MG/PACKET
Approval Date : 2025-05-30
Application Number : 214410
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Genentech is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of CED88004S bulk offered by Genentech
Find a price of THROMBOPOIETIN (HUMAN, RECOMBINANT, CHO CELLS, GENENTECH) bulk offered by Genentech
Find a price of CED88004A bulk offered by Genentech
Find a price of TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G bulk offered by Genentech
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SOUTH SAN FRANCISCO. bulk offered by Genentech
Find a price of DORNASE ALFA INHALATION SOLUTION (GENENTECH) bulk offered by Genentech
